EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Determination of Seroprevalence of Chronic Hepatitis B, C and D: A Cross‐Sectional Study From Türkiye

Muhammet Salih Tarhan iD

Public Health Nursing · 2026

DOI: 10.1111/phn.70148 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Public Health Nursing, 2026. Verfasst von Muhammet Salih Tarhan. Beteiligte Einrichtung: Department of Infectious Diseases and Clinical Microbiology, Mardin Training and Research Hospital, Mardin, Türkiye. Hauptthemen laut MEDLINE: Hepatitis B, Chronic, Hepatitis C, Chronic, Hepatitis D, Chronic. Die Arbeit nennt 23 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

This study aimed to determine the seroprevalence of hepatitis B, C, and D in Mardin, Türkiye, identify at‐risk populations, and evaluate the effect of the hepatitis B vaccination program.

Methods

HBsAg, anti‐HBs, anti‐HBc IgG, anti‐HCV and anti‐HDV results were analysed retrospectively.

Results

Among the 30430 patients (60.2% female) tested, seropositivity rates were 2.1% for HBsAg, 55.2% for anti‐HBs, 27.8% for anti‐HBc IgG, and 0.14% for anti‐HCV; of HBsAg‐positive patients, 6.1% were anti‐HDV positive. After adjusting for Mardin's age distribution, the age‐weighted rates were 1.48%, 56.3%, 15.9%, 0.12%, and 6.2% (for anti‐HDV in adults). Those born after 1998 (aged ≤ 26), when hepatitis B vaccination began nationally, had significantly lower HBsAg (0.3% vs. 2.8%) and anti‐HBc IgG (2.5% vs. 36.6%) positivity, and higher anti‐HBs (59.1% vs. 53.4%) positivity, than older individuals ( p < 0.001). In a subgroup of 2703 with all hepatitis B markers, vaccine‐induced immunity was more frequent in those aged ≤ 26 years (55.4% vs. 22.0%), while natural immunity (1.5% vs. 26.7%) and chronic infection (0.6% vs. 4.9%) were more common in those aged ≥ 27 years ( p < 0.001).

Conclusion

This large‐scale survey in Mardin shows that hepatitis B vaccination reduced prevalence, highlighting the need for targeted screening and public health nursing interventions in older adults.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hepatitis B, ChronicHepatitis C, ChronicHepatitis D, ChronicHumansFemaleSeroepidemiologic StudiesCross-Sectional StudiesAdultMiddle AgedMaleRetrospective StudiesTurkeyAgedAdolescentYoung AdultHepatitis B Surface AntigensChildHepatitis B Vaccines

Stichwörter der Autor:innen

hepatitis Bhepatitis Chepatitis Dseroprevalence

Substanzen

Hepatitis B Surface AntigensHepatitis B Vaccines

Autor:innen und Institutionen

  • Department of Infectious Diseases and Clinical Microbiology, Mardin Training and Research Hospital, Mardin, Türkiye.

ORCID-Profile: Muhammet Salih Tarhan

Zitieren

APA

Tarhan, M. S. (2026). Determination of Seroprevalence of Chronic Hepatitis B, C and D: A Cross‐Sectional Study From Türkiye. Public Health Nursing. https://doi.org/10.1111/phn.70148

Vancouver

Tarhan MS. Determination of Seroprevalence of Chronic Hepatitis B, C and D: A Cross‐Sectional Study From Türkiye. Public Health Nursing. 2026. doi:10.1111/phn.70148

BibTeX
@article{Tarhan2026,
  author = {Tarhan, Muhammet Salih},
  title = {Determination of Seroprevalence of Chronic Hepatitis B, C and D: A Cross‐Sectional Study From Türkiye},
  journal = {Public Health Nursing},
  year = {2026},
  doi = {10.1111/phn.70148}
}
Kostenlos starten →